Moderna will not be the company to fulfill President Donald Trump's wish for a coronavirus vaccine by Election Day, the firm's CEO said Wednesday. Moderna's vaccine candidate - mRNA-1273 - is nearing the finish line in its push to enroll 30,000 individuals in a late-stage trial of a novel coronavirus vaccine. Bancel had previously warned that if infection rates decline in the US, it could delay the progress of Moderna's vaccine trial. US officials plan to ship the first doses within 24 hours of the FDA issuing emergency use authorization or approving a vaccine. White House Chief of Staff Mark Meadows has said that the US will have 100 million doses of coronavirus vaccine by the end of October and 300 million by January.

Source: Daily Mail September 30, 2020 19:12 UTC